Cargando…
Transient deterioration of albumin–bilirubin scores in early post-dose period of molecular targeted therapies in advanced hepatocellular carcinoma with 50% or higher liver occupation: A STROBE-compliant retrospective observational study
Real-world clinical cases of molecularly targeted agent (MTA) administration to patients with advanced hepatocellular carcinoma (HCC) with ≥50% liver occupation have been reported, but treatment outcomes have rarely been described. We have encountered several cases in which albumin–bilirubin (ALBI)...
Autores principales: | Muto, Hisanori, Kuzuya, Teiji, Ito, Takanori, Ishizu, Yoji, Honda, Takashi, Ishikawa, Tetsuya, Ishigami, Masatoshi, Fujishiro, Mitsuhiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8341339/ https://www.ncbi.nlm.nih.gov/pubmed/34397843 http://dx.doi.org/10.1097/MD.0000000000026820 |
Ejemplares similares
-
Limitation of non-transplant treatment and proper timing for liver transplantation in patients with hepatocellular carcinoma considering long-term survival
por: Nomura, Aya, et al.
Publicado: (2020) -
Successful Treatment of Hepatocellular Carcinoma with Regorafenib after Sorafenib-induced Hypersensitivity
por: Yoshioka, Naoki, et al.
Publicado: (2019) -
The albumin–bilirubin score as a predictor of outcomes in Japanese patients with PBC: an analysis using time-dependent ROC
por: Ito, Takanori, et al.
Publicado: (2020) -
Molecular characteristics of colorectal serrated polyps and hyperplastic polyps: A STROBE compliant article
por: Sambuudash, Otgontuya, et al.
Publicado: (2016) -
Palliation of malignant dysphagia with a segmented self-expanding metal stent: A STROBE-compliant article
por: Wiese, Marie-Sophie, et al.
Publicado: (2021)